Healthcare Archivi - Pagina 6 di 7

20 giugno 2023

Battling and Defeating Cancer With Immunotherapy Drugs

It is quite common to find people suffering from cancer. Cancer was once considered untreatable, but it is not the case with all the developments going on in medical science.

Cancer has everything to do with putting bad impact of the body, that’s why the body is not able to recognize the cancer cells and fight with them. In this blog, there will be information about immunotherapy, which is a particularly recent treatment for cancer.

Immunotherapy utilizes the immune system of a person for battling cancer. It usually has fewer side effects than a chemotherapy treatment.

Immunotherapy is done on the basis of immune cells that have the potential of recognizing and killing cancer cells can be produced in the labs and given to patients for the treatment of cancer. Several immunotherapy drugs have got the approval by the FDA or are in the process of clinical trials for determining their efficiency in treating various cancers.

Preparing Immune System To Fight Cancer

Immunotherapies makes use of different methods for battling with cancer cells. There are generally three types of Immunotherapies:

Checkpoint inhibitors- It is that process, which disturbs the system of cancer cell signals dodging the immune system into thinking they’re healthy, exposing them, and get them attacked by the immune system

Cytokines- cytokines helping in regulating and directing the immune system are formulated in a lab and injected into the body in larger dose than that, which are produced naturally in the human body.

Cancer vaccines- These are vaccines which reduce the risk of cancer by launching an open attack on the cancer causing viruses, or might help in the treatment of cancers by motivating the immune system for attacking cancer cells in a precise body part.

Immunotherapy might be put to use alone or in combination with other cancer treatments, for example surgery, chemotherapy, radiation and targeted therapy.

Immunotherapy Vs Chemotherapy

Both immunotherapy and chemotherapy are usually employed treatments of cancer using drugs put a halt or slow the rate of growth of cancerous cells. Though, while chemotherapy drugs attack quickly producing cells all over the body, immunotherapy activates the immune system’s capability to recognize and attack the cells causing cancer.

What are the Benefits of Immunotherapy

Immunotherapies are less common than chemotherapy as a cancer treatment. But these therapies are a treatment option for various cancers.

Immunotherapies can be more comprehensive and less noxious than other treatments used for treating cancer, as they harness the body power to attack the cancer cells rather than inserting chemicals into the body.

Immunotherapies are an active area of research in cancer therapy, and many of the new treatments are waiting to be approved for use for the treatment of cancer.

Due to the increasing prevalence of Chronic diseases around the world, the demand for immunotherapy drugs will further increase in the years to come, and will reach a value of USD 210,752 million by the end of this decade.

19 giugno 2023

North America Is Dominating Surgical Sutures Industry

The total value of the global surgical sutures market was USD 4.1 billion in 2021, and it will rise at a growth rate of above 5.9% shortly, reaching USD 6.8 billion by 2030, according to P&S Intelligence. This development can be credited to the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe.

In recent years, absorbable sutures led the industry, with a market share of above 52%, and the same is also estimated to be in the leading position throughout the forecast period. This is mainly because of its timings, as it takes less time and reduces the count of patient visits to hospitals.

Internal operations regularly use absorbable sutures because they naturally and securely break in the body. Hydrolytic, proteolytic, and enzymatic devices are utilized to degrade these sutures. Reliant on the material used for the process, the breakdown procedure characteristically takes 9 days to 8 weeks. Different materials, polyglycolic acid, including catgut, polylactic acid, and polydioxanone, are utilized to make absorbable sutures.

In 2021, the cardiovascular surgery category had the largest surgical sutures market share, approximately 30.0%, because of the rising occurrence of cardiovascular illnesses. Cardiovascular operations, such as heart transplantation operations, are undertaken to cure difficulties of valvar heart illnesses, ischemic heart illnesses, and congenital heart illnesses.

Surgical procedures involving cardiovascular systems are the most complex and high-risk, necessitating sutures of the highest quality and suitability. An increase in the number of patients with heart disorders leads to a rise in the usage of cardiovascular surgeries, boosting the demand for sutures in the market.

In recent years, the North American region dominated the industry by generating the highest revenue share, of over 40%. This can be credited to the growing elderly populace, the growing count of road accidents, the rising cases of obesity and diabetes, and the growing burn cases in the continent.

Furthermore, the augmented requirement for improved surgical techniques and products, including biocompatible surgical sutures with antimicrobial coatings, is boosting the development of the industry in North America.

Hence, the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe are the major factors propelling the surgical sutures market.

14 giugno 2023

The Evolution Of The Healthcare Ecosystem

The healthcare ecosystem insights report shelters a comprehensive study of the healthcare sector in the U.K., the U.S., Germany, China, Singapore, France, and Japan.

The development of the industry in the seven countries can be credited to the growing count of cases of chronic illnesses, growing acceptance of healthcare insurance, growing demand for in-vitro diagnostic (IVD) tests, thriving elderly populace, rising gross domestic product (GDP) and healthcare investments, government initiatives, advancing healthcare infrastructure, and fast digitization in the medicinal ecosystem.

Based on type, the cardiovascular and circulatory diseases category, is projected to generate the highest revenue of more than 42.6% in Germany, experiencing a CAGR of 3.3% in the coming few years. This is mainly because cardiovascular disorders (CVDs) are the most widespread chronic diseases in the nation. The cancer category is estimated to be the second-largest category in the German industry, with a 26.5% share, in the coming years.

On the basis of channel, in recent years, the state/local category had the third position in the Japanese industry, accounting for more than 17.4% industry share. This was because fewer healthcare facilities are provided at the state/local level in the nation.

Industry Dynamics

The healthcare sector development in the seven nations is boosted by the rise in the elderly populace, growing demand for IVD tests, digitalization in the healthcare industry, and widescale acceptance of healthcare insurance. The Elderly has a direct link with chronic illnesses, like CVDs, neurological circumstances, and rheumatoid arthritis.

The growing life expectancy and lessening death rates are the main contributors to the growing elderly populace throughout the world. As per the World Bank, the populace of individuals aged 65 years or above grew from 34.2 million in 2017 to 40.1 million in 2021 in Japan and from 13.2 million in 2017 to 19 million in 2021 in France.

Additionally, an analysis by the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) of Japanese people old 75 years and more exposed that more than 65% of these people were living with at least three co-occurring illnesses, like coronary heart disease, hypertension, and peptic ulcers. Since elder people are extremely vulnerable to these ailments, the growing elderly populace in such nations will boost the requirement for medicine and other medical amenities in the coming years.

Furthermore, the rising demand for IVD tests will ease the healthcare sector development in the coming few years. The growing utilization of IVD tests can be credited to their fast and dependable outcomes, smooth information recording capability, to confirm the results, simple repeatability, numerous tests performing ability, and skill to sense an extensive variety of substances in the body.

For example, China is generating a high demand for such tests because of the growing occurrence of chronic diseases among the elderly populace, several of which can be identified and monitored via IVD products. Moreover, the growing acceptance of health insurance guidelines is having a positive effect on market development, as health insurance decreases the financial load on patients.

8 giugno 2023

Defibrillator Industry Is Dominated by North America

As per a report by P&S Intelligence, the defibrillator market will advance at a rate of 7.2%, to reach USD 20,281.6 million, by 2030.

Key factors driving the growth of the industry are the rising number of strategic developments among key players, quick advancements in defibrillator technology, and the increasing incidence of cardiac diseases.

Based on type, the ICDs category accounted for the larger share of the industry in recent years, and it is likely to dominate the industry throughout this decade. This is credited to the growing emphasis of players on developing technologically advanced ICDs and rising product launches.

In the past few years, the adult patient type category accounted for the larger share of the industry, and it will demonstrate faster growth in the years to come. This is because the incidence of sudden cardiac arrest in the adult population is significantly higher than in the elderly population.

A key trend observed in the defibrillator industry is the deployment of automated external defibrillators in public spaces, for instance, airports, leisure centers, shopping centers, railway stations, malls, and colleges & schools.

Over the past few years, numerous developments have been made in the defibrillation technology. For instance, ZOLL Medical Corporation developed a lightweight defibrillator LifeVest that can be worn easily by patients at risk of SCA. This device monitors the heart rhythm of the patient regularly and when it detects any abnormality it produces a shock for restoring the normal heart rhythm.

In the past few years, the players in the industry have been involved in strategic developments, for instance, product launches, to maintain a competitive edge.

It is because of the increasing prevalence of cardiac diseases, the rising elderly population, and advancement in defibrillation technology, the growth of the defibrillator industry will continue to grow in the years to come.

8 giugno 2023

Radiotherapy Industry Generated the Highest Revenue in North America

The radiotherapy market will advance at a rate of 8.4% in the years to come to reach USD 17,194.4 million by 2030. The growing frequency of cancer and increasing acceptance of advanced treatment procedures are the key factors supporting the growth of the market.

External-Beam Equipment will observe the fastest growth in the years to come. In this radiation therapy high-energy X-ray radiation is transported to tumors within the body of the patient by a machine outside it.

Hospitals generated the highest revenue in the recent past, as stated by a market expert at P&S Intelligence. This is because most of the radiotherapy processes are done at hospitals, in the supervision of trained healthcare specialists, as a result of their intricacy.

APAC radiotherapy market will grow the fastest in the years to come. The main factors supporting this industry growth include the increasing burden of cancer, inciting investments by public and private organizations, and improving healthcare infra.

The rising burden of continuing diseases is disturbing LMICs, in addition to high-income countries. For example, cancer is one of the most-dominant chronic illnesses globally.

As per the American Institute of Cancer Research, by 2030, the count of new cancer cases will reach about 25 million. Most of these cases will be recorded in LMICs, for example China and India.

Tech progressions in treatment protocols have powered the requirement of the demand for automated products, which can be combined into clinical practice systems for reducing the time and surge the efficiency of treatments. As a result of these expansions, the market will have a positive effect in the future. With tech progressions, there has been a widespread emphasis on the enhancement of patient care.

Moreover, the obtainability of automated, more-efficient, and innovative clinical tools in radiation therapy and arrival of SBRT, IMRT, IGRT, VMAT, SRS, proton therapy, and brachytherapy, are contributing significantly to the growth of the industry for radiotherapy equipment.

Increasing healthcare expenditure all over the world, has a lot to do with the increasing requirement for radiotherapy, in the years to come.

6 giugno 2023

North America ISOs Medical Device and Equipment Maintenance and Calibration Services Market Was Dominated in the U.S.

The North America ISOs medical device and equipment maintenance and calibration services market will grow at a rate of 8.9% in the years to come, to reach USD 3,612.9 million by 2030, as stated by a market research institution, P&S Intelligence.

The key factors responsible for the industry growth are progressions in the medical device sector, increase in consciousness regarding preventive medical equipment maintenance, and strict regulatory environment.

The patient monitoring and electromedical category will grow the fastest in the years to come. This has a lot to do with the high incidence of chronic ailments, such as cardiac and respiratory, increasing aging population, and growing number of ICU beds.

The U.S. had a larger share in the North America ISOs medical device and equipment maintenance and calibration services market, and the nation will continue the same way in the years to come. This is mostly because of the occurrence of a large count of hospitals and established players and rise in tech progressions with regards to diagnostic tests.

Medical devices can be employed in numerous applications, not being precise to just one area.

Furthermore, these services also aid in averting infections brought about by the usage of medical devices throughout surgeries.

Therefore, the importance on cleanliness in healthcare institutions is increasing, with a number of prestigious administrations delivering guidance for improving cleanliness and averting infections.

For example, the WHO has given guidelines for hospital hygiene, emphasizing equipment maintenance for infection control.

The incidence of a strict regulatory framework makes medical paraphernalia maintenance a required prerequisite for end users in North America.

For instance, the U.S. CMS regulations and other accreditation necessities TJC, HFAP, and DNV, along with guidelines by OEMs and the USFDA, necessitate compliance with regards to equipment maintenance amongst hospitals.

It is because of the advancements in medical industry, the demand for medical device and equipment maintenance and calibration services in North America will be on the rise in the years to come.

2 giugno 2023

Interventional Vascular Consumables Industry Growth and Demand Forecast to 2030

The total value of the global interventional vascular consumables market was USD 3,929.2 million in 2021, and it will rise at a growth rate of above 3.8% shortly, reaching USD 5,501.7 million by 2030, according to P&S Intelligence.

This growth can be attributed to the growing count of CVD cases throughout the world is boosting the need for interventional vascular procedures. For example, as per the WHO, approximately 17.9 million individuals expire of CVDs per annum, representing 32.0% of all worldwide demises.

In 2021, the consumables utilized in coronary interventional events generated the highest revenue share of approximately 80%. The growing occurrence of coronary heart illness, related to the growing elderly populace, is directing to the rising demand for the consumables utilized during coronary procedures.

In 2021, North America dominated the interventional vascular consumables market with the largest share, 35.2%. The supremacy of the region in the industry is majorly credited to the increasing healthcare investments, growing count of cases of chronic illnesses, and increasing elderly populace.

As per a report in the U.S., issued by the Rural Health Information Hub, 46 million individuals were aged 65 and more in 2020, and this count is set to surge to nearly 90 million by 2050. The thriving elderly populace leads to the increasing occurrence of chronic illnesses, therefore causing a high requirement for interventional vascular consumables in the continent.

Interventional procedures are favored by elder patients as such procedures have a lesser danger of complications and are inexpensive. Furthermore, they are chosen as with age, patients’ capability to heal the marks of the operation might reduce.

Hence, the growing count of CVD cases throughout the world is boosting the need for interventional vascular procedures.

23 maggio 2023

North America Is Dominating Rapid Test Kit Industry

In 2022, the rapid test kit market was worth around USD 23,043.3 million, and it is projected to advance at a 9.1% CAGR from 2022 to 2030, hitting USD 46,139.9 million in 2030, according to P&S Intelligence.

Rapid tests are utilized for initial screening, and for the initial analysis of illnesses. Because of their dependability and quick results, they have extensive applications.

Furthermore, credited to their lucrative and easy-use nature, the diagnoses can be completed with ease of one’s home, which is another factor they are gaining more and more traction in the industry. The increasing infectious disease occurrence, surge in the importance of knowledge of early diagnoses, and growing elderly populace positively impacted the demand for such tests.

The outburst of the novel coronavirus resulted in the sudden and massive development of the industry, because of the growth in the need for quick diagnostic solutions, to eventually stop the serious, life-intimidating difficulties of the virus.

The terror of infectious infection results in individuals accepting such quick point-of-care diagnostic kits to identify the virus early stage, from the ease of their houses. The orders for the accessibility of such kits by governments at several public and private hospitals also boosted the growth of the market.

The increasing frequency of foodborne illnesses leads to a surge in the utilization of rapid diagnostic kits to classify the existence of contaminants, through the testing of a food sample, to avoid difficulties.

Benefits like, specificity, high sensitivity, fast results the capability to spot viruses existing to a low extent, and the removal of the restrictions of orthodox testing approaches make enhanced rapid tests more popular, thus fuelling the market growth. Furthermore, such diagnostic tests are enabled to remove human mistakes, save time and reduce labor.

In 2022, the hospitals and clinics category held the largest rapid test kit market share, of around 50%, on the basis of end users. This can be credited to the surging occurrence of the novel coronavirus infection caused a high hospitalization rate. This multitudes the number of partnerships between the main industry players and several steps by governments worldwide to guarantee the accessibility of test kits for the initial diagnosis of COVID-19, to avoid further damages.

North America had the largest market share, of approximately 45%, in 2022. This can be credited to the existence of deep-rooted medicinal companies in the continent, strong healthcare infrastructure, and high knowledge among the people regarding maintaining well-being.

Hence, with the help of these kits, the diagnoses can be completed with ease of one’s home and also the increasing infectious disease occurrence, the surge in the importance of knowledge of early diagnoses, and the growing elderly populace are major factors driving the rapid test kit market.

22 maggio 2023

Vascular Patches Industry Development, Demand and Forecast Report 2030

The vascular patches market had the revenue of USD 387.3 million in 2022, which will power at a CAGR of 8.1% in the years to come, to touch a value of USD 724.2 million by 2030.

The main risk for patients now is multi-morbidity, denoting the concurrent occurrence of two or more chronic ailments. Approximately 80% of the adults aged 65 and above have two or more chronic ailments, and 68% have three or more.

The biological category had a larger share of revenue, about 60%, in 2022, and it will maintain its dominance in the years to come. This is because biological variants are extensively used for closing the arteries during cardiac surgeries.

These patches have more than a few advantages over their synthetic counterparts, such as advanced compatibility with the living tissue, less toxic, lesser risk of immunological refusals, and ease of usage. They also minimalize suture line bleeding and decrease the probabilities of infection.

The CEA category had the largest share, about 40% in the past, because of the increase in the number of these surgeries. A methodical review of randomized clinical trials found that patch angioplasty in conventional CEA could decrease the risk of a recurring restenosis and ipsilateral stroke, associated to a main closure.

Also, vascular bypass surgery will observe a considerable growth in the years to come as a result of the accessibility of reimbursement in developing and developed economies.

North American vascular patches market dominated with about 40% share, in 2022 as per a report by P&S Intelligence, a market research institution. This has a lot to do with the constant growth in healthcare technologies, fast changing lifestyles, increasing incidence of cardiac ailments and hernia, growing consumption of tobacco and alcohol, rising obesity levels, and increasing substance abuse.

Furthermore, the increasing frequency of product introductions and the commercialization of state-of-the-art treatments power advance of the industry. The region also dominates the market because of the progressions in its healthcare infra and a beneficial insurance compensation situation for vascular treatments.

Furthermore, Europe follows North America due to the presence of prominent research organizations and market players, and the favorable regulations of governments that inspire surgeries for the predictive management of ailments.

Also, Germany is showing momentous growth. This is because of the increase in its healthcare budget, acceptance of cutting-edge technologies, promising reimbursement policy for vascular procedures, and robust preference for surgeries amongst healthcare staffs for CHDs.

It is because of the increasing prevalence of vascular disorders, the demand for vascular patches is increasing, and will increase considerably by the end of this decade.

18 maggio 2023

Veterinary Pain Management Industry Will Reach $2.78 Billion By 2030

In 2022, the veterinary pain management market was worth around USD 1.60 billion, and it is projected to advance at a 7.10% CAGR from 2022 to 2030, hitting USD 2.78 billion by 2030, according to P&S Intelligence.

This development can be credited to the growing occurrence of musculoskeletal syndromes, including osteoarthritis, in animals, also the increasing acceptance of buddy and livestock animals. Furthermore, the developments in the animal healthcare industry have led to the increasing requirement for veterinary pain management items.

In 2022, the drug category led the product segment, with a veterinary pain management market share of above 88%, credited to the growing utilization of nonsteroidal anti-inflammatory drugs for painkilling resolves in animals.

Thus, NSAIDs are leading the drug category as they are widely utilized in curing osteoarthritis-associated pain and irritation in animals. Furthermore, the key industry players are creating novel NSAIDs in order to reduce the side effects and reactions instigated by the prevailing ones.

In the coming few years, the joint pain category is projected to develop at the highest CAGR, of above 7.6%, mainly because of the growing count of pets, increasing quantity of overweight or obese pets, and rising occurrence of chronic illnesses, including osteoarthritis, in animals.

In the joint pain category, osteoarthritis held the highest revenue share, because of the mounting incidence of this condition, particularly in the dog family. NSAIDs and coxibs are given for mild-to-severe osteoarthritis aching, while nutraceuticals are desirable for moderate osteoarthritis pain. The most-used medicines for joint disorders such as Metacam, Rimadyl, Meloxicam, and Galliprant.

During the forecast period, the growing incidence of animal syndromes that cause pain and irritation is estimated to boost the development of the worldwide veterinary pain management industry. There are numerous inflammatory illnesses in pets, including cryptococcosis, canine distemper, coccidioidomycosis, rabies, neosporosis, and toxoplasmosis, also chronic illnesses, including chronic kidney disease cancer, and arthritis, most of which have pain as a warning sign.

In 2022, North America dominated the industry, with a market share of approximately 42%, and it is further projected to be on the leading spot, rising at a significant CAGR, in the coming few years.

This is mainly because of the rising occurrence of several infections, including those instigated by pests, which are resulting in the usage of animal antibiotics.

Other main boosters are the increasing ownership of friend animals, thriving knowledge regarding animal well-being, and the growing quantity of veterinary clinics in the continent.

Moreover, the existence of all main industry players in the continent will contribute to boosting the industry for veterinary pain management solutions.

Hence, the growing occurrence of musculoskeletal syndromes, including osteoarthritis, in animals, also the increasing acceptance of buddy and livestock animals, are the major factors propelling the veterinary pain management market.